SEC Form 4 research
| Issuer | Edgewise Therapeutics, Inc. |
|---|---|
| Tickers | EWTX |
| Reporting owners | 26 |
| Officers and directors | 11 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-01 | Fox Jonathan C | A | 308 | $0 | Not reported |
| 2026-08-17 | 2026-08-12 | Russell Alan J | A | 65,000 | $0 | Not reported |
| 2026-08-17 | 2026-08-12 | Derakhshan Behrad | A | 100,000 | $0 | Not reported |
| 2026-08-17 | 2026-08-12 | Nofi Michael | A | 48,750 | $0 | Not reported |
| 2026-08-17 | 2026-08-12 | Donovan Joanne M. | A | 65,000 | $0 | Not reported |
| 2026-08-17 | 2026-08-12 | MOORE JOHN R | A | 65,000 | $0 | Not reported |
| 2026-08-14 | 2026-08-12 | Russell Alan J | S | 390 | $44.46 | Not reported |
| 2026-08-14 | 2026-08-12 | Russell Alan J | S | 2,273 | $43.68 | Not reported |
| 2026-08-14 | 2026-08-12 | Russell Alan J | S | 3,238 | $43.68 | Not reported |
| 2026-08-14 | 2026-08-12 | Russell Alan J | A | 65,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.